The SPCC (Sharing Progress in Cancer Care) webinar, titled “HER2DX: Translating Biology into Care,” is scheduled for June 16, 2026, at 06:00 PM (CEST).

This educational session will focus on the HER2DX genomic assay and its clinical role in translating tumor biology into personalized care for patients with HER2-positive breast cancer. The faculty will discuss the biological foundations of the assay, its genomic components, and its practical utility in risk stratification and multidisciplinary treatment decision-making.

The distinguished panel of speakers features experts from the Hospital Clínic of Barcelona, Spain:

Aleix Prat – Discussant (Hospital Clínic of Barcelona)
Marta González – Expert (Medical Oncologist, Breast Cancer Research Program, Fundació Clínic per a la Recerca Biomèdica [FCRB] at Hospital Clínic de Barcelona)
Francesco Schettini – Expert (Medical Oncology Department, Translational Genomics and Targeted Therapies in Solid Tumors Group, FRCB-IDIBAPS, Hospital Clínic of Barcelona)

This work is funded by the European Union with additional funding support received from the Swiss State Secretariat for Education, Research and Innovation (SERI).